Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

IEP

Icahn Enterprises Reports Widening Loss in Q2

Icahn Enterprises reported a sharply wider second-quarter loss as revenue rose year over year, while the value of its asset base fell by $765 million from the prior quarter.

For the three months ended June 30, 2026, revenue increased to $3.0 billion from $2.4 billion a year earlier, a gain of $600 million, or 25%. Despite that top-line increase, net loss attributable to IEP widened to $355 million from $165 million in the 2025 quarter, an increase of $190 million. Loss per depositary unit increased to $0.52 from $0.30.

Adjusted EBITDA swung to a loss of $134 million in the quarter, compared with adjusted EBITDA of $40 million in the second quarter of 2025, a decline of $174 million.

For the first half of 2026, revenue rose to $5.2 billion from $4.2 billion in the first half of 2025, up $1.0 billion, or about 24%. Net loss attributable to IEP increased to $814 million from $587 million, a rise of $227 million. Loss per depositary unit widened to $1.22 from $1.08. Adjusted EBITDA loss deepened to $350 million from $188 million, a deterioration of $162 million.

Indicative net asset value stood at about $2.6 billion at June 30, 2026, down $765 million from March 31. The company said the decline was driven mainly by a $435 million drop in the value of its long position in CVI and a $243 million reduction tied to the holding company’s interest in investment funds, largely from net losses on broad market hedges.

The board declared a second-quarter distribution of $0.50 per depositary unit. As a result of these announcements, the company's shares have moved -3.82% on the market, and are now trading at a price of $7.435. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS